Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmace Supply Disruption — PAI Holdings, LLC. dba Pharma
Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmace Supply Disruption — PAI Holdings, LLC. dba Pharma is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmace; Manufacturer: PAI H
| Drug name | Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmace |
|---|---|
| Manufacturer | PAI Holdings, LLC. dba Pharmaceutical Associates Inc |
| Recall/Disruption reason | Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0723-2021 |
| Initiation date | 20210729 |
| Quantity affected | 75 cases (6 bottles/case) |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →